We are delighted to be part of the ACROSS Heart Failure steering committee, which continually produces up-to-date, scientifically robust content and develops the programme to support our multidisciplinary colleagues involved in the treatment of heart failure.
The programme is sponsored by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.
-
“ACROSS HF provides a very educational, evidence based update on outcomes and mechanistic aspects of SGLT2 inhibitors in patients with heart failure.” Nikolaus Marx
-
“The ACROSS HF platform is an evidence-based and balanced portfolio” Shelley Zieroth
